Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VI-0521 (Qsymia) Extension in Type 2 Diabetes
NCT00737633Phase 2Terminated
- Sponsor
- VIVUS
- Start
- Aug 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phentermine + topiramate in type 2 diabetes mellitus (T2DM), sponsored by VIVUS. Started Aug 2008; status: terminated.
02
Drugs
phentermine + topiramate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00737633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737633.